The Management Board approves and monitors implementation of ECDC’s work programme and budget, it adopts its annual report and accounts - all in all, it acts as the governing body of the Centre. It meets at least twice a year.
In January 2008, a panel of ECDC experts produced the Guidance for the introduction of HPV vaccines in EU countries. Since then, the European Union has come a long way: most countries have implemented national vaccination programmes for adolescent girls and a significant number have also introduced catch-up programmes for young women.
The seventh update of the ECDC Rapid Risk Assessment on MERS-CoV addresses the changed epidemiological situation since the previous Rapid Risk Assessment, provides travel advice regarding visits to Saudi Arabia for the Umrah or Hajj pilgrimage, and assesses the risk of importation of MERS-CoV to the EU.
This protocol presents a common methodology to estimate vaccine effectiveness (VE) for COVID-19, using established health data registries in participating EU/EEA Member States.
This handbook proposes strategies that build on the experiences of immunisation information system (IIS) experts; provides case studies from actual programmes to highlight particular aspects of IIS practice, including functionalities, benefits, challenges, and implementation.
A systematic review of seroprevalence and incidence comprising European surveillance data and national vaccination recommendations. This report provides a comprehensive picture of Hepatitis A virus (HAV) infection epidemiology in the EU/EEA between 1975 and 2014.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 3-9 June 2018 and includes updates on dengue, Vibrio growth in the Baltic Sea, measles, rubella, hepatitis A, mass gathering monitoring, Carbapenem-resistant Enterobacteriaceae, Ebola virus disease, West Nile virus, polio and MERS-CoV.